Acute Febrile Illness Clinical Trial
Official title:
Causes of Acute Undifferentiated Fever and the Utility of Biomarkers in Differentiating Bacterial From Viral Infection Among Acute Febrile Patients in Northwest Ethiopia
A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in differentiating bacterial from viral infection among acute febrile patients in Gondar, northwest Ethiopia.
General objective: To assess the causes of acute undifferentiated febrile illness and evaluation of biomarkers for differentiation of bacterial and viral infections among outpatients at University of Gondar (UOG) Hospital, Northwest Ethiopia Specific objectives 1. To determine the number of malaria cases, bacterial infections (by blood culture and polymearase chain reaction (PCR) for Rickettsia and Borrelia), and arboviral infections (DENV, YFV, CHIKV) among all acute febrile patients 2. To evaluate the diagnostic performance different assays (RDT, RT-(reverse transcriptase)PCR, ELISA) for the diagnosis of DENV 3. To evaluate the qualitative detection of C-reactive protein (CRP) and Myxovirus resistance protein (MxA) (by FebriDx RDT) and quantitative CRP detection for differentiating bacterial and viral infections Study design, population, materials and methods: a cross-sectional cohort study on febrile patients presenting with acute fever at the emergency ward of the UOG hospital from June to August 2019. Clinical and epidemiological data will be recorded in a pseudo-anonymized and collected using an electronic data collection tool (KoBoToolbox). Blood will be collected for RDT testing, blood culture, PCR and serum for ELISA and RT-PCR. Sample size: 200 acute febrile patients Expected results and relevance: Evaluation of the causes of acute febrile illness and the role of biomarkers in differentiating viral and bacterial infections will increase the awareness of circulating pathogens and improve patient management. This evidence will contribute to a more rational use of laboratory diagnostic tests, antibiotics and antimalarial treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03943654 -
Improving Nighttime Access to Care and Treatment (Part 2)
|
||
| Completed |
NCT04299412 -
Diagnostic Accuracy of the DPP II Assay
|
||
| Completed |
NCT04299607 -
Evaluation of the DPP II Assay in Laos
|
||
| Recruiting |
NCT05050825 -
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal
|
N/A | |
| Recruiting |
NCT04878549 -
Transcriptomic Responses for the Identification of Pathogens
|
||
| Recruiting |
NCT04629053 -
Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
|
||
| Completed |
NCT02763462 -
The Etiology of Acute Febrile Illness Requiring Hospitalization
|
||
| Recruiting |
NCT05292508 -
Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
|
N/A | |
| Completed |
NCT01403350 -
Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan
|
Phase 4 | |
| Completed |
NCT02225769 -
Electronic Algorithms Based on Host Biomarkers to Manage Febrile Children
|
N/A | |
| Completed |
NCT04081051 -
Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention
|
N/A |